207 related articles for article (PubMed ID: 32584606)
1. Delayed contrast dynamics as marker of regional impairment in pulmonary fibrosis using 5D MRI - a pilot study.
Buzan MT; Wetscherek A; Rank CM; Kreuter M; Heussel CP; Kachelrieß M; Dinkel J
Br J Radiol; 2020 Sep; 93(1113):20190121. PubMed ID: 32584606
[TBL] [Abstract][Full Text] [Related]
2. Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias.
Traila D; Oancea C; Tudorache E; Mladinescu OF; Timar B; Tudorache V
J Int Med Res; 2018 Jan; 46(1):448-456. PubMed ID: 28758849
[TBL] [Abstract][Full Text] [Related]
3. Free-breathing dynamic contrast-enhanced magnetic resonance of interstitial lung fibrosis.
Frenk NE; Montesi SB; Chen T; Liang LL; Zhou I; Seethamraju R; Caravan P; Digumarthy SR
Magn Reson Imaging; 2020 Jun; 69():16-21. PubMed ID: 32126265
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
[TBL] [Abstract][Full Text] [Related]
5. Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling.
Salisbury ML; Xia M; Murray S; Bartholmai BJ; Kazerooni EA; Meldrum CA; Martinez FJ; Flaherty KR
Respir Med; 2016 Sep; 118():88-95. PubMed ID: 27578476
[TBL] [Abstract][Full Text] [Related]
6. The use of exhaled air analysis in discriminating interstitial lung diseases: a pilot study.
Plantier L; Smolinska A; Fijten R; Flamant M; Dallinga J; Mercadier JJ; Pachen D; d'Ortho MP; van Schooten FJ; Crestani B; Boots AW
Respir Res; 2022 Jan; 23(1):12. PubMed ID: 35057817
[TBL] [Abstract][Full Text] [Related]
7. Utility of expiratory thin-section CT for fibrotic interstitial pneumonia.
Tokura S; Okuma T; Akira M; Arai T; Inoue Y; Kitaichi M
Acta Radiol; 2014 Nov; 55(9):1050-5. PubMed ID: 24252818
[TBL] [Abstract][Full Text] [Related]
8. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
Lamb YN
Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
[TBL] [Abstract][Full Text] [Related]
9. Decrease of pulmonary blood flow detected by phase contrast MRI is correlated with a decrease in lung volume and increase of lung fibrosis area determined by computed tomography in interstitial lung disease.
Tsuchiya N; Yamashiro T; Murayama S
Eur J Radiol; 2016 Sep; 85(9):1581-5. PubMed ID: 27501892
[TBL] [Abstract][Full Text] [Related]
10. Can FDG-PET/CT imaging be used to predict decline in quality of life in interstitial lung disease? A prospective study of the relationship between FDG uptake and quality of life in a UK outpatient setting.
Jordon LH; Ganeshan B; Nadeem I; Hoy L; Mahdi N; Porter JC; Groves A; Win T
BMJ Open; 2024 May; 14(5):e081103. PubMed ID: 38816048
[TBL] [Abstract][Full Text] [Related]
11. Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality.
Tsitoura E; Trachalaki A; Vasarmidi E; Mastrodemou S; Margaritopoulos GA; Kokosi M; Fanidis D; Galaris A; Aidinis V; Renzoni E; Tzanakis N; Wells AU; Antoniou KM
Front Immunol; 2021; 12():645548. PubMed ID: 34867934
[TBL] [Abstract][Full Text] [Related]
12. Deep learning diagnostic and severity-stratification for interstitial lung diseases and chronic obstructive pulmonary disease in digital lung auscultations and ultrasonography: clinical protocol for an observational case-control study.
Siebert JN; Hartley MA; Courvoisier DS; Salamin M; Robotham L; Doenz J; Barazzone-Argiroffo C; Gervaix A; Bridevaux PO
BMC Pulm Med; 2023 Jun; 23(1):191. PubMed ID: 37264374
[TBL] [Abstract][Full Text] [Related]
13. Quantification of MRI T2 Interstitial Lung Disease Signal-Intensity Volume in Idiopathic Pulmonary Fibrosis: A Pilot Study.
Benlala I; Albat A; Blanchard E; Macey J; Raherison C; Benkert T; Berger P; Laurent F; Dournes G
J Magn Reson Imaging; 2021 May; 53(5):1500-1507. PubMed ID: 33241628
[TBL] [Abstract][Full Text] [Related]
14. Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases.
Torrisi SE; Kahn N; Wälscher J; Sarmand N; Polke M; Lars K; Eichinger M; Heussel CP; Palmucci S; Sambataro FM; Sambataro G; Sambataro D; Vancheri C; Kreuter M
BMC Pulm Med; 2019 Nov; 19(1):213. PubMed ID: 31718637
[TBL] [Abstract][Full Text] [Related]
15. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
Feng H; Zhao Y; Li Z; Kang J
Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
[TBL] [Abstract][Full Text] [Related]
16. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
[TBL] [Abstract][Full Text] [Related]
17. [Chronic fibrosing lung diseases : Idiopathic pulmonary fibrosis from the perspective of its differential diagnosis].
Dartsch RC; Fink L; Breithecker A; Markart P; Tello S; Seeger W; Günther A
Internist (Berl); 2019 Apr; 60(4):345-361. PubMed ID: 30887071
[TBL] [Abstract][Full Text] [Related]
18. Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors.
Korfei M; von der Beck D; Henneke I; Markart P; Ruppert C; Mahavadi P; Ghanim B; Klepetko W; Fink L; Meiners S; Krämer OH; Seeger W; Vancheri C; Guenther A
J Proteomics; 2013 Jun; 85():109-28. PubMed ID: 23659799
[TBL] [Abstract][Full Text] [Related]
19. T2 mapping of CT remodelling patterns in interstitial lung disease.
Buzan MT; Eichinger M; Kreuter M; Kauczor HU; Herth FJ; Warth A; Pop CM; Heussel CP; Dinkel J
Eur Radiol; 2015 Nov; 25(11):3167-74. PubMed ID: 26037715
[TBL] [Abstract][Full Text] [Related]
20. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.
Desai SR; Veeraraghavan S; Hansell DM; Nikolakopolou A; Goh NS; Nicholson AG; Colby TV; Denton CP; Black CM; du Bois RM; Wells AU
Radiology; 2004 Aug; 232(2):560-7. PubMed ID: 15286324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
